However, in our study, a negative correlation was found between mutations of epigenetic-related genes and recurrence, and there was no prognostic significance demonstrated for ARID1A. In fact, epigenetic dysregulations occur in different stages of various tumors; this can be either a cause or an effect of tumor recurrence and progression. The gene discussed is ARID1A; the disease is neoplasm.